Glen Harbor Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Glen Harbor Capital Management's GILD Position: Q3 2019 in Review
Glen Harbor Capital Management increased its Gilead Sciences (GILD) stake by 27% in Q3 2019, buying an estimated $2.05M and bringing the position to 147,620 shares worth $9.36M. The position accounts for 0.19% of the portfolio, ranked #101.
Glen Harbor Capital Management first reported a position in GILD in Q4 2016 and has held it in 12 quarters since. The position peaked at $49.8M in Q4 2016. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.
- Glen Harbor Capital Management held 147,620 shares of Gilead Sciences worth $9.36M as of Q3 2019.
- Glen Harbor Capital Management bought 31,416 Gilead Sciences shares in Q3 2019, an estimated $2.05M.
- Gilead Sciences made up 0.19% of Glen Harbor Capital Management's portfolio in Q3 2019, its #101 holding.
- Glen Harbor Capital Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 12 quarters since.
- Glen Harbor Capital Management's Gilead Sciences position peaked at $49.8M in Q4 2016.
- 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.
Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.